Robot pump aims to tame blood sugar in High-Risk dialysis patients
NCT ID NCT06330194
Summary
This study tested a new automated insulin delivery system for people with diabetes who also have advanced kidney disease or are on dialysis. The goal was to see if this 'artificial pancreas' system could better control blood sugar levels compared to usual care. Fifteen participants tried the system for eight weeks, and researchers measured how much time their blood sugar stayed in a healthy range.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tobias Bomholt
Copenhagen, 2100, Denmark
Conditions
Explore the condition pages connected to this study.